专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO0166085A3 MICELLAR PHARMACEUTICAL COMPOSITIONS FOR BUCCAL AND PULMONARY APPLICATION 审中-公开
标题翻译：用于乳腺和脉搏应用的MICELLAR药物组合物
公开(公告)号：WO0166085A3
公开(公告)日：2002-04-11
申请号：PCT/IB0100515
申请日：2001-02-21
申请人： GENEREX PHARM INC
发明人： MODI PANKAJ
IPC分类号： A61K9/72 , A61K9/00 , A61K9/107 , A61K9/66 , A61K31/56 , A61K31/7088 , A61K31/7105 , A61K31/711 , A61K31/727 , A61K38/00 , A61K38/21 , A61K38/22 , A61K38/28 , A61K39/395 , A61K45/00 , A61K47/04 , A61K47/06 , A61K47/08 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/16 , A61K47/20 , A61K47/22 , A61K47/24 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , A61K47/44 , A61K47/46 , A61K48/00 , A61P3/10 , A61P5/00 , A61P7/02 , A61P29/00 , A61P31/00 , A61P31/12 , A61P31/16 , A61P31/18 , A61P43/00 , A61K9/12
CPC分类号： A61K9/1075 , A61K9/006 , A61K9/008 , Y10S514/946 , Y10S514/95 , Y10S514/951
摘要： Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about 1 and 10 nanometers. Methods for making and using the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth.
摘要翻译：公开了包含混合胶束形式的大分子药剂的药物组合物。混合的胶束由碱金属烷基硫酸盐和至少三种不同胶束形成化合物形成，如说明书中所述。胶束尺寸介于约1至10纳米之间。还公开了制备和使用组合物的方法。用于施用本发明组合物的优选方法是通过口腔的颊部区域。

2. 发明申请

WO2004016244A2 PHARMACEUTICAL COMPOSITIONS FOR BUCCAL DELIVERY OF PAIN RELIEF MEDICATIONS 审中-公开
标题翻译：用于输送疼痛缓解药物的药物组合物
公开(公告)号：WO2004016244A2
公开(公告)日：2004-02-26
申请号：PCT/IB0303914
申请日：2003-08-14
申请人： GENEREX PHARM INC
发明人： MODI PANKAJ
IPC分类号： A61K47/20 , A61K9/00 , A61K9/107 , A61K9/12 , A61K31/4468 , A61K31/485 , A61K38/28 , A61K45/06 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/22 , A61K47/34 , A61K47/42 , A61P25/04
CPC分类号： A61K45/06 , A61K9/0019 , A61K9/006 , A61K9/1075 , A61K31/4468 , A61K31/485 , A61K38/28 , A61K47/10 , A61K47/20 , Y10S514/946 , A61K2300/00
摘要： PHARMACEUTICAL COMPOSITIONS FOR BUCCAL DELIVERY OF PAIN RELIEF MEDICATIONS
摘要翻译：用于输送疼痛缓解药物的药物组合物

3. 发明申请

WO2004054636A3 CLEANING COMPUND FOR AND METHOD OF CLEANING VALVES AND ACTUATORS OF METERED DOSE DISPENSERS CONTAINING PHARMACEUTICAL COMPOSITIONS 审中-公开
标题翻译：清洁计量器和用于清洁含药物组合物的计量剂量分配器的阀和执行器的方法
公开(公告)号：WO2004054636A3
公开(公告)日：2004-10-28
申请号：PCT/IB0306417
申请日：2003-12-16
申请人： GENEREX PHARM INC , MODI PANKAJ
发明人： MODI PANKAJ
IPC分类号： A61M15/00 , B08B9/00 , C09K3/30 , C11D7/22 , C11D7/50
CPC分类号： A61M15/009 , B08B9/00 , C09K3/30 , C11D7/22 , C11D7/50
摘要： A method of cleaning a metered dose spray device, and a cleaning composition for such cleaning, prevent the device from becoming clogged with medication. The method includes removing the aerosol can containing the medication from the actuator, placing an aerosol can containing a cleaning composition in the actuator, and dispensing the cleaning solution through the actuator. The residual medication is thereby removed from the actuator. A sufficiently small quantity of cleaning composition remains in the actuator so that the cleaning composition itself will not clog the actuator. Additionally, the cleaning composition is non-toxic, so that residual cleaning composition remaining in the actuator will not harm the user when a subsequent dose of medication is dispensed.
摘要翻译：清洁计量剂量喷雾装置的方法和用于这种清洁的清洁组合物防止装置被药物堵塞。该方法包括从致动器移除含有药物的气溶胶罐，将含有清洁组合物的气雾剂罐放置在致动器中，并且通过致动器分配清洁溶液。残余药物因此从致动器中被去除。足够少量的清洁组合物保留在致动器中，使得清洁组合物本身不会阻塞致动器。另外，清洁组合物是无毒的，使得残留在致动器中的清洁组合物在分配后续剂量的药物时不会伤害使用者。

4. 发明申请

WO2004016243A3 METHODS OF ADMINISTERING AND ENHANCING ABSORPTION OF PHARMACEUTICAL AGENTS 审中-公开
标题翻译：管理和增强药物吸收的方法
公开(公告)号：WO2004016243A3
公开(公告)日：2004-05-21
申请号：PCT/IB0303908
申请日：2003-08-14
申请人： GENEREX PHARM INC
发明人： MODI PANKAJ
IPC分类号： A61K9/00 , A61K9/107 , A61K31/4468 , A61K31/485 , A61K38/28 , A61K45/06 , A61K47/10 , A61K47/20
CPC分类号： A61K9/008 , A61K9/0019 , A61K9/006 , A61K9/1075 , A61K31/4468 , A61K31/485 , A61K38/28 , A61K45/06 , A61K47/10 , A61K47/20 , B82Y5/00 , Y10S514/866 , Y10S514/946 , A61K2300/00
摘要： Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about l and 10 nanometers. Methods for administering the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth, which has been demonstrated to achieve peak plasma levels of the pharmaceutical agent in about thirty minutes.
摘要翻译：公开了包含混合胶束形式的大分子药剂的药物组合物。混合胶束由碱金属烷基硫酸盐和至少三种不同的胶束形成化合物形成，如说明书中所述。胶束尺寸介于约1和10纳米之间。还公开了施用组合物的方法。用于给予本发明组合物的优选方法是通过口腔的口腔颊部区域，已经证明其在大约三十分钟内达到药剂的血浆峰值水平。

5. 发明申请

WO0172278A3 METHOD FOR ADMINISTERING INSULIN TO THE BUCCAL REGION 审中-公开
标题翻译：将胰岛素施用于BUCCAL区域的方法
公开(公告)号：WO0172278A3
公开(公告)日：2002-04-11
申请号：PCT/IB0100564
申请日：2001-02-21
申请人： GENEREX PHARM INC
发明人： MODI PANKAJ
IPC分类号： A61K9/00 , A61K9/107 , A61K38/12 , A61K38/28
CPC分类号： A61K9/0043 , A61K9/0056 , A61K9/006 , A61K9/1075 , A61K38/00 , A61K38/28
摘要： A mixed micellar pharmaceutical formulation includes a micellar proteinic pharmaceutical agent, an alkali metal C8 to C22 alkyl sulphate, alkali metal salicylate, a pharmaceutically acceptable edetate and at least one absorption enhancing compounds. The absorption enhancing compounds are selected from the group consisting of lecithin, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linolenic acid, borage oil, evening of primrose oil, trihydroxy oxo cholanylglycine, glycerin, polyglycerin, lysine, polylysine, triolein and mixtures thereof. The amount of each absorption enhancing compound is present in a concentration of from 1 to 10 wt./wt.% of the total formulation, and the total concentration of absorption enhancing compounds are less than 50 wt./wt.% of the formulation.
摘要翻译：混合胶束药物制剂包括胶束蛋白质药剂，碱金属C8至C22烷基硫酸盐，碱金属水杨酸盐，药学上可接受的盐酸盐和至少一种吸收增强化合物。吸收增强化合物选自卵磷脂，透明质酸，透明质酸的药学上可接受的盐，辛基苯氧基聚乙氧基乙醇，乙醇酸，乳酸，洋甘菊提取物，黄瓜提取物，油酸，亚麻酸，琉璃苣油，月见草油的晚上，三羟基羰基甘氨酸甘油，甘油，聚甘油，赖氨酸，聚赖氨酸，三油酸甘油酯及其混合物。每种吸收增强化合物的量以总制剂的1至10重量/重量％的浓度存在，并且吸收增强化合物的总浓度小于制剂的50重量/重量％。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式